Federal appeals court partially reverses ruling in BRCA patents case

[News]

In a 2-1 decision, a federal appeals court today partially reversed a lower court's ruling in a case challenging patents on two human genes, BRCA1 and BRCA2, associated with hereditary breast and ovarian cancer. The court ruled that companies can obtain patents on the genes but cannot patent methods to compare those gene sequences.

More... (http://www.news-medical.net/news/20110803/Federal-appeals-court-partially-reverses-ruling-in-BRCA-patents-case.aspx)